vTv Therapeutics Inc (VTVT)
24.15
+0.02
(+0.08%)
USD |
NASDAQ |
Apr 17, 16:00
24.58
+0.42
(+1.76%)
After-Hours: 20:00
vTv Therapeutics Cash from Investing (TTM)
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2018 | 0.007M |
| September 30, 2018 | -0.011M |
| June 30, 2018 | 0.026M |
| March 31, 2018 | 0.026M |
| December 31, 2017 | -0.025M |
| September 30, 2017 | -0.007M |
| June 30, 2017 | -0.039M |
| March 31, 2017 | -0.122M |
| December 31, 2016 | -0.083M |
| Date | Value |
|---|---|
| September 30, 2016 | -0.12M |
| June 30, 2016 | -0.129M |
| March 31, 2016 | -0.075M |
| December 31, 2015 | -0.079M |
| September 30, 2015 | 0.154M |
| June 30, 2015 | 0.154M |
| March 31, 2015 | 0.174M |
| December 31, 2014 | 0.161M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Altimmune Inc | 13.73M |
| Palatin Technologies Inc | 9.293M |
| Oragenics Inc | -0.9363M |
| Viking Therapeutics Inc | -179.09M |
| G1 Therapeutics Inc | 2.81M |